Longitude Capital Management Co., LLC

Longitude Capital Management Co., LLC is a private investment firm specializing in venture growth investments in drug development, medical technology, and health solutions companies. Established in 2006, the firm operates from offices in Menlo Park, California, and Boston, Massachusetts. Longitude Capital serves as an investment adviser to pooled investment vehicles exempt from registration under the Investment Company Act of 1940. The firm's principal owners are Juliet Tammenoms Bakker and Patrick Enright. Longitude Capital manages Clients' assets on a discretionary basis, with $2,080,004,000 managed as of December 31, 2024. The firm receives an annual management fee from each Fund it advises, typically up to 2.0% for core venture Funds and 1% for opportunities Funds. Longitude Capital does not participate in wrap fee programs and may receive additional compensation from portfolio companies. The firm's investment strategy focuses on venture growth investments and special situations, with an "opportunities" Fund targeting later-stage opportunities. Longitude Capital has a formal written policy governing the allocation of expenses among the Funds. The firm has a Code of Ethics in place, ensuring fiduciary duties to Clients and compliance with securities laws. Longitude Capital does not engage in soft dollar arrangements and votes proxies in the best interests of Clients. The firm does not maintain physical custody of Clients' assets but adheres to the Custody Rule requirements. Longitude Capital provides investment advice on a discretionary basis to the Funds, voting proxies in line with Clients' best interests. The firm has not been subject to legal or disciplinary events in the past ten years. Clients can request additional information on the firm's practices and policies.